Live Breaking News & Updates on Gelita

Stay informed with the latest breaking news from Gelita on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Gelita and stay connected to the pulse of your community

Study finds collagen peptides reduce knee joint discomfort

Tests carried out on collagen peptides suggests they may play a role in reducing the intensity of knee joint pain in healthy adults, potentially delaying the onset of chronic degenerative joint diseases.
In a German-Austrian research collaboration, the team found a five gram(g) oral daily dosage of Gelita’s Fortigel bioactive collagen peptides had a
“positive effect” on knee joint pain during activity when compared with placebo.
“I welcome the new addition to the portfolio of studies,” says Dr Stephan Hausmanns, Gelita’s Vice President for Health & Nutrition.
“Fortigel is the most clinically-studied bioactive collagen peptide for 30 years.
“Over 20 studies, involving more than 2,500 participants, contributed to develop Fortigel and prove the product’s positive effects to joint health.

Germany , Austria , Vienna , Wien , Gelita-fortigel , Stephan-hausmanns , Health-nutrition , Vice-president , Bioactive-collagen-peptide , Research , Protein , Proteins